UNSPSC 51373435: Citric/codeine/ipecac/potassium/promethazine/sodium

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373435 Citric/codeine/ipecac/potassium/promethazine/sodium, a Commodity code, covers pharmaceutical products and medical supplies that state and local governments procure for correctional healthcare, public health, and emergency response. Recent solicitations show state and local agencies buying parenteral nutrition solutions, intravenous medications, naloxone, and related pharmaceutical products to support incarcerated populations and community health initiatives. The Washington State Department of Corrections and Seminole County, Florida represent the issuing-body types active under this code — state agencies operating correctional systems and county health departments managing public health procurement. Work solicited includes preparation and delivery of customized parenteral nutrition formulations (TPN and PPN), intravenous solutions containing controlled substances, naloxone distribution systems, and drug deactivation products, with vendors required to demonstrate pharmaceutical preparation expertise, compliance with state licensure and background-clearance requirements, and ability to meet tight delivery windows (24-hour turnarounds for nutrition products, 8-hour windows for other parenteral medications).

Activity under this code centers in the Pacific Northwest and Southeast. Washington State and Florida have posted recent opportunities. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, requesting quotes for parenteral products, services, and equipment to supply eight correctional facilities across three regions, with a response deadline of October 7, 2026 at 4:00 PM PST and a pre-bid conference on September 23, 2026; DOC anticipates selecting up to three contractors per region and offers 25% small-business, 10% minority-owned, 6% women-owned, and 5% veteran-owned business participation goals under Chapter 39.19 RCW. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, soliciting annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building, with an initial two-year term and one-year renewal option. Both opportunities require comprehensive commercial general liability, professional liability, and cyber liability insurance; vendors must maintain state business licensure and pass background clearance.